Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells

Nutrition and Cancer

Volumn 33, Issue 1, 1999, Pages 105-112

  Amir, Hadar ^a   Karas, Michael ^a   Giat, Judith ^a   Danilenko, Michael ^a   Levy, Rachel ^a   Yermiahu, Tikva ^a   Levy, Joseph ^a   Sharoni, Yoav ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD14 ANTIGEN; LYCOPENE; NITROBLUE TETRAZOLIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION;

EID: 0033008852     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589909514756     Document Type: Article

References (52)

1. Block, G, Patterson, B, and Subar, A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1-29, 1992.
2. Van Poppel, G: Carotenoids and cancer: an update with emphasis on human intervention studies. Eur J Cancer 29A, 1335-1344, 1993.
3. Hennekens, CH, Buring, JE, Manson, JE, Stampfer, M, Rosner, B, et al.: Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149, 1996.
4. Greenberg, ER, Baron, JA, Tosteson, TD, Freeman, DH, Beck, GJ, et al.: Clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 331, 141-147, 1994.
5. Heinonen, OP, Huttunen, JK, Albanes, D, Haapakoski, J, Palmgren, J, et al.: Effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035, 1994.
6. Omenn, GS, Goodman, GE, Thornquist, MD, Balmes, J, Cullen, MR, et al.: Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155, 1996.
7. VanEenwyk, J, Davis, FG, and Bowen, PE: Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 48, 34-38, 1991.
8. Helzlsouer, KJ, Comstock, GW, and Morris, JS: Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer. Cancer Res 49, 6144-6148, 1989.
9. Burney, PG, Comstock, GW, and Morris, JS: Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 49, 895-900, 1989.
10. Goodman, MT, Kolonel, LN, Wilkens, LR, Yoshizawa, CN, Lemarchand, L, et al.: Dietary factors in lung cancer prognosis. Eur J Cancer 28, 495-501, 1992.
11. Giovannucci, W, Ascherio, A, Rimm, EB, Stampfer, MJ, Colditz, GA, et al.: Intake of carotenoids and retinol in relation to risk of prostate cancer. JNCI 87, 1767-1776, 1995.
12. Wang, C-J, and Un, J-K: Inhibitory effects of carotenoids and retinoids on the in vitro growth of rat C-6 glioma cells. Proc Natl Sci Counc Repub China B 13, 176-183, 1989.
13. Countryman, C, Bankson, D, Collins, S, Man, B, and Lin, W: Lycopene inhibits the growth of the HL-60 promyelocytic leukemia cell line (abstr). Clin Chem 37, 1056, 1991.
14. Levy, J, Bosin, E, Feldman, B, Giat, Y, Miinster, A, et al.: Lycopene is a mote potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 24, 257-267, 1995.
15. Wang, CJ, Chou, MY, and Lin, JK: Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids. Cancer Lett 48, 135-142, 1989.
16. Nagasawa, H, Mitamura, T, Sakamoto, S, and Yamamoto, K: Effect of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res 15, 1173-1178, 1995.
17. Sharoni, Y, Giron, E, Rise, M, and Levy, J: Effects of lycopene enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect Prev 21, 118-123, 1997.
18. Gallagher, R, Collins, S, Trujillo, J, McCredie, K, Ahearn, M, et al.: Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54, 713-733, 1979.
19. Collins, SJ: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70, 1233-1244, 1987.
20. Prossnitz, ER, Quehenberger, O, Cochrane, CG, and Ye, RD: Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells. J Immunol 151, 5704-5715, 1993.
21. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102, 937-943, 1981.
22. McCarthy, DM, San Miguel, JF, Freake, HC, Green, PM, Zola, H, et al.: 1,25-Dihydroxyvitamin D, inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res 7, 51-55, 1983.
23. Breitman, TR, Selonick, SE, and Collins, SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77, 2936-2940, 1980.
24. 3, retinoic acid and DMSO. Leuk Res 19, 57-64, 1995.
25. Bollag, W, Majewski, S, and Jablonska, S: Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia 8, 1453-1457, 1994.
26. Warrell, RP, Jr, Frankel, SR, Miller, WH, Jr, Scheinberg, DA, Itri, LM, et al.: Differentiation therapy of acute promyelocytic leukemia with tretmom (all-trans-retinoic acid). N Engl J Med 324, 1385-1393, 1991.
27. Chen, ZX, Xue, YQ, Zhang, R, Tao, RF, Xia, XM, et al.: A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78, 1413-1419, 1991.
28. Christakos, S, Raval Pandya, M, Wernyj, RP, and Yang, W: Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D,. Biochem J 316, 361-371, 1996.
29. Chen, A, Licht, JD, Wu, Y, Hellinger, N, Scher, W, et al.: Retinoic acid required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood 84, 2122-2129, 1994.
30. 3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol Res 9, 19-29, 1997.
31. Sokoloski, JA, Hodnick, WF, Mayne, ST, Cinquina, C, Kim, CS, et al.: Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D-3: possible relationship to NF-κ Β. Leukemia 11, 1546-1553, 1997.
32. Stahl, W, Sundquist, AR, Hanusch, M, Schwarz, W, and Sies, H: Separation of β-carotene and lycopene geometrical isomers in biological samples. Clin Chem 39, 810-814, 1993.
33. Levy, R, Rotrosen, D, Nagauker, O, Leto, TL, and Malech, HL: Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J Immunol 145, 2595-2601, 1990.
34. Kizaki, M, Ikeda, Y, Tanosaki, R, Nakajima, H, Morikawa, M, et al.: Effect of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptors-α and retinoid X receptors-α RNA by HL-60 cells. Blood 82, 3582-3599, 1993.
35. Drexler, HG, Quentmeier, H, MacLeod, RA, Uphoff, CC, and Hu, ZB: Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk Res 19, 681-691, 1995.
36. Studzinski, GP, McLane, JA, and Uskokovic, MR: Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Cm Rev Eukaryot Gene Expr 3, 279-312, 1993.
37. Ferrero, E, Hsieh, CL, Francke, U, and Goyert, SM: CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J Immunol 145, 331-336, 1990.
38. Sharoni, Y, and Levy, J: Anticarcinogenic properties of lycopene. In Natural Antioxidants and Food Quality in Atherosclerosis and Cancer Prevention, JT Kumpulainen and JK Salonen (eds). Cambridge, UK: R Soc Chem, 1996, pp 378-385.
39. Wise, JA, Morin, RJ, Sanderson, R, and Blum, K: Changes in plasma carotenoid, α-tocopherol, and lipid peroxide levels in response to supplementation with concentrated fruit and vegetable extracts: a pilot study. Curr Ther Res 57, 445-461, 1996.
40. 3. J Cell Physiol 163, 502-509, 1995.
41. 3 in HL60 cells. Cancer Res 56, 264-267, 1996.
42. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10, 142-153, 1996.
43. James, SY, Williams, MA, Kelsey, SM, Newland, AC, and Colston, KW: Interaction of vitamin D derivatives and granulocyte-macrophage colony-stimulating factor in leukaemic cell differentiation. Leukemia 11, 1017-1025, 1997.
44. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia 9, 410-418, 1995.
45. 3 on the differentiation of the human monocytic cell line U937. Leuk Res 15, 1145-1152, 1991.
46. 3-induced monocytic differentiation of U937 cells. Leuk Res 20, 665-676, 1996.
47. 3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Cell Growth Differ 7, 1239-1249, 1996.
48. Narisawa, T, Fukaura, Y, Hasebe, M, Ito, M, Aizawa, R, et al.: Inhibitory effects of natural carotenoids, α-carotene, β-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107, 137-142, 1996.
49. Franceschi, S, Bidoli, E, La Vecchia, C, Talamini, R, D'Avanzo, B, et al.: Tomatoes and risk of digestive-tract cancers. Int J Cancer 59, 181-184, 1994.
50. Gross, MD, and Snowdon, DA: Plasma antioxidant concentrations in a population of elderly women: findings from the nun study. Nutr Res 16, 1881-1890, 1996.
51. Buiatti, E, Munoz, N, Kato, I, Vivas, J, Muggli, R, et al.: Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer. Int J Cancer 65, 317-322, 1996.
52. Boosalis, MG, Snowdon, DA, Tully, CL, and Gross, MD: Acute phase response and plasma carotenoid concentrations in older women: findings from the nun study. Nutrition 12, 475-478, 1996.